News
Epredia Launches SlideMate™ Thermal Slide Printer, Delivering On-Demand Slide Printing and Enhanced Traceability for Pathology Laboratories
New Solution Expands Epredia Lineup of Pathology Innovations Including Award-Winning SlideMate™ Laser
May 14, 2026 – Epredia, a global leader in precision cancer diagnostics solutions and a subsidiary of PHC Holdings Corporation (TSE: 6523), today announced that it has launched sales of the SlideMate™ Thermal Slide Printer (TSP). SlideMate TSP is the newest addition to the company’s SlideMate portfolio of slide printers, which are used in pathology laboratories to identify and help track tissue samples.
Building on the technology of its award-winning SlideMate Laser printer, Epredia has engineered the SlideMate TSP to help clinical laboratories of any size to protect tissue samples, strengthen sample traceability, and streamline workflow efficiency during cancer diagnosis. The SlideMate TSP creates crisp, permanent thermal transfer printing on microscope slides with modernized features designed to maximize product performance and reduce laboratory workflow interruptions. These features include enclosed slide hoppers to protect samples from potential dust contamination and mechanical slide movement that offers smoother handling than gravity-fed solutions. The SlideMate TSP allows pathology labs to keep pace with high-volume demands while maintaining consistent print quality.
In addition to its modernized features, the SlideMate TSP’s compact size allows for seamless integration into any histology, cytology, or other pathology workflow. When used in conjunction with Epredia LabWriter software, it can easily interface with a Laboratory Information System.
The SlideMate TSP is the latest addition to Epredia’s world-class portfolio of precision cancer diagnostics products and services that provide a seamless end-to-end laboratory workflow. Epredia also offers optimized slides designed for use with the SlideMate TSP, including non-adhesion slides with Superfrost technology and adhesion slides with Superfrost PLUS technology to maximize tissue adherence. Slides are available in multiple colors, which laboratories can use to coordinate downstream activities.
SlideMate TSP is manufactured in Italy, and is the newest technology to come out of PHC Group’s San Benedetto del Tronto facility.
About Epredia
Epredia is a global leader in the anatomical pathology field, providing comprehensive solutions for precision cancer diagnostics and tissue diagnostics. Powered by key brands, including Erie Scientific, Menzel-Gläser, Microm, Shandon, and Richard-Allan Scientific, Epredia’s portfolio includes microscope slides, instruments and consumables. Epredia was established following the acquisition of Thermo Fisher Scientific’s Anatomical Pathology business by PHC Holdings (TSE 6523) in 2019. Epredia has manufacturing sites in the United States, the United Kingdom, Italy, France, and China with a total of around 1,200 employees. Epredia is committed to achieving its mission to improve lives by enhancing cancer diagnostics for patients around the world. For further information on Epredia and its products, please visit www.epredia.com.
About PHC Holdings Corporation (PHC Group)
PHC Holdings Corporation (TSE 6523) is a global collection of healthcare companies with a mission of contributing to the health of society through healthcare solutions that have a positive impact and improve the lives of people. Its subsidiaries (referred to collectively as PHC Group) include PHC Corporation, Epredia, Ascensia Diabetes Care, LSI Medience Corporation, Wemex Corporation and Mediford Corporation. Together, these companies develop, manufacture, sell and service solutions across diabetes management, healthcare solutions, life sciences and diagnostics. PHC Group’s consolidated net sales in FY2025 were JPY 364 billion with global distribution of products and services in more than 125 countries and regions.
Media Contact:
Julia Cottrill
PHC Group Corporate Communications